Mankind Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE634S01028
NSEID: MANKIND
BSEID: 543904
View on NSE | View on BSE

INR

2,475.95

-53.8 (-2.13%)

BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 5.98 lacs

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,475.95",
    "chg": -53.8,
    "chgp": "-2.13%",
    "dir": -1,
    "prev_price": "2,529.75",
    "mcapval": "105,520.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "02:20 AM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "5.98 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-price-action-4070742",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4070742.png",
        "date": "2026-06-24 15:01:03",
        "description": "Mankind Pharma Ltd has witnessed a notable 12.17% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock underperforming its sector and broader indices. This surge in open interest, coupled with rising volumes and shifting investor positioning, offers important clues about potential directional bets and market sentiment for this mid-cap pharmaceutical player."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4069278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4069278.png",
        "date": "2026-06-23 15:00:14",
        "description": "Mankind Pharma Ltd has witnessed a notable 15.11% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and the broader Sensex, reflecting a complex interplay between bullish bets and short-term profit-taking."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amid-mixed-market-signals-4069235",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4069235.png",
        "date": "2026-06-23 14:00:12",
        "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 16.23% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a slight price dip of 0.72% on 23 Jun 2026, the stock’s underlying metrics and trading volumes suggest a complex interplay of bullish and bearish bets among market participants."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4069198",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4069198.png",
        "date": "2026-06-23 13:00:13",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal decline in the stock price, the pharmaceutical mid-cap’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Sustained Gains and Elevated Volume",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-sustained-gains-and-elevated-volume-4069144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4069144.png",
        "date": "2026-06-23 12:00:10",
        "description": "Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical mid-cap, currently rated a Buy with a Mojo Score of 72.0, has been gaining steadily over the past five days, reflecting growing investor confidence despite a slight underperformance relative to its sector."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amidst Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amidst-strong-market-momentum-4069114",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4069114.png",
        "date": "2026-06-23 11:00:08",
        "description": "Mankind Pharma Ltd has witnessed a notable 12.48% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor sentiment. This surge accompanies a steady price rally and rising volumes, suggesting a growing bullish bias among traders in the mid-cap pharmaceutical stock."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4068658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_oi_spurts_by_underlying_4068658.png",
        "date": "2026-06-23 10:00:10",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and bullish positioning among investors. The stock’s recent outperformance, coupled with rising volumes and sustained gains, suggests growing confidence in the pharmaceuticals and biotechnology mid-cap’s near-term prospects."
      },
      {
        "title": "Mankind Pharma Ltd Surges 5.14% to Day's High of Rs 2536.55 — Outperforms Sector by 3.59 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-hits-intraday-high-with-514-surge-on-22-june-2026-4067646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MankindPharmaLt_priceRelatedfactors_4067646.png",
        "date": "2026-06-22 15:17:51",
        "description": "The Sensex edged up 0.42% on 22 Jun 2026, but Mankind Pharma Ltd outpaced the broader market with a 5.14% gain, reaching an intraday high of Rs 2536.55. This 3.59 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Mankind Pharma Gains 1.59%: Technical Upgrades and Strong Financials Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-gains-159-technical-upgrades-and-strong-financials-drive-momentum-4065278",
        "imagepath": "",
        "date": "2026-06-20 11:02:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Week opens at ₹2,380.60 with marginal gain</p>\n                    <p><strong>16 Jun:</strong> Stock dips 1.00% amid low volume</p>\n                    <p><strong>18 Jun:</strong> Sharp rebound with 1.75% gain following positive technical signals</p>\n                    <p><strong>19 Jun:</strong> MarketsMOJO upgrades rating to Buy; stock closes at ₹2,417.35 (+0.52%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,380.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-valu..."
      }
    ],
    "total": 545,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-Jun-2026",
      "details": "Please find attached intimation regarding participation in investor conference by management and officials of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "08-Jun-2026",
      "details": "Please find attached Intimation regarding Change in Management.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "08-Jun-2026",
      "details": "Allotment of 86778 Equity Shares under Mankind Employee Stock Option Plan 2022 (ESOP PLAN)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action

2026-06-24 15:01:03

Mankind Pharma Ltd has witnessed a notable 12.17% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock underperforming its sector and broader indices. This surge in open interest, coupled with rising volumes and shifting investor positioning, offers important clues about potential directional bets and market sentiment for this mid-cap pharmaceutical player.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-06-23 15:00:14

Mankind Pharma Ltd has witnessed a notable 15.11% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and the broader Sensex, reflecting a complex interplay between bullish bets and short-term profit-taking.

Read full news article

Mankind Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-06-23 14:00:12

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 16.23% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a slight price dip of 0.72% on 23 Jun 2026, the stock’s underlying metrics and trading volumes suggest a complex interplay of bullish and bearish bets among market participants.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-06-23 13:00:13

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal decline in the stock price, the pharmaceutical mid-cap’s derivatives market shows signs of increased speculative interest, raising questions about potential directional bets and future price movements.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Sustained Gains and Elevated Volume

2026-06-23 12:00:10

Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical mid-cap, currently rated a Buy with a Mojo Score of 72.0, has been gaining steadily over the past five days, reflecting growing investor confidence despite a slight underperformance relative to its sector.

Read full news article

Mankind Pharma Sees Significant Open Interest Surge Amidst Strong Market Momentum

2026-06-23 11:00:08

Mankind Pharma Ltd has witnessed a notable 12.48% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor sentiment. This surge accompanies a steady price rally and rising volumes, suggesting a growing bullish bias among traders in the mid-cap pharmaceutical stock.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-06-23 10:00:10

Mankind Pharma Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and bullish positioning among investors. The stock’s recent outperformance, coupled with rising volumes and sustained gains, suggests growing confidence in the pharmaceuticals and biotechnology mid-cap’s near-term prospects.

Read full news article

Mankind Pharma Ltd Surges 5.14% to Day's High of Rs 2536.55 — Outperforms Sector by 3.59 Percentage Points

2026-06-22 15:17:51

The Sensex edged up 0.42% on 22 Jun 2026, but Mankind Pharma Ltd outpaced the broader market with a 5.14% gain, reaching an intraday high of Rs 2536.55. This 3.59 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.